Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Busch and Timothy Henrich.
Michael Busch
Connection Strength
0.927
Timothy Henrich
  1. A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 11 02; 73(9):e2845-e2846.
    View in: PubMed
    Score: 0.244
  2. Correction to: Rapid development of HIV elite control in a patient with acute infection. BMC Infect Dis. 2019 Oct 22; 19(1):877.
    View in: PubMed
    Score: 0.212
  3. Rapid development of HIV elite control in a patient with acute infection. BMC Infect Dis. 2019 Sep 18; 19(1):815.
    View in: PubMed
    Score: 0.211
  4. Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. Blood Adv. 2018 12 11; 2(23):3479-3482.
    View in: PubMed
    Score: 0.200
  5. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv. 2021 Jul; 7(31).
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.